Based on our findings, disruption of taurine transport through blockage of taurine import/export gene TauT using relevant antibodies or small molecular inhibitors might be a potential adjuvant treatment to attenuate this macrophage‐tumor cell crosstalk to restore the sensitivity to ferroptosis in PCa in clinics. The gene discussed is SLC6A6; the disease is neoplasm.